Clinical Trial Update: Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing mulberry twig alkaloid tablet to canagliflozin in adults with type 2 diabetes is ongoing or not yet updated in status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)
• Mulberry Twig Alkaloid Tablet (unknown)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN